Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy.

Masaya Jimbo Jack R Andrews Mohamed E Ahmed Alan H BryceR Jeffrey KarnesAlan H BryceAyse T KendiEugene D KwonVal J LoweMichael S Bold

Published in: The Prostate (2021)

Our study showed that mid-course and posttherapy 11C-choline PET/CT evaluation for mCRPC patients undergoing primary docetaxel chemotherapy can predict full course treatment response and PFS, respectively. 11C-choline PET/CT imaging may provide valuable prognostic information to guide treatment choices for patients with mCRPC.

Keyphrases

pet ct
locally advanced
prostate cancer
patients undergoing
positron emission tomography
rectal cancer
squamous cell carcinoma
high resolution
computed tomography
radical prostatectomy
radiation therapy
magnetic resonance imaging
healthcare
magnetic resonance
chemotherapy induced
fluorescence imaging